Depemokimab has the potential to be the first approved ultra-long-acting biologic with six month dosing, offering physicians ... the first completely new antibiotic to treat and complicated ...

Correspondence to Dr Penelope A Bryant, The Royal ... on a drug chart and an HITH care plan documenting the reason for treatment. The reason was documented on the HITH care plan for 267/269 (99%) ...

Background Children ... their antibiotic prescribing,7 study physicians reviewed detailed symptoms, physical examination findings and diagnostic tests to assess the appropriateness of the patient’s ...

“Dosing adolescents is the first step in evaluating the safety and PK of nomlabofusp in pediatric patients with FA. We continue to enroll adolescents in our first cohort. This cohort will be ...

Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult ...

Doctors are sounding the alarm about a common antibiotic taken by millions that ... Dr Jennifer Goldman, a pediatric infectious disease specialist at Children's Mercy Kansas City, said: 'These ...

“Dosing adolescents is the first step in evaluating the safety and PK of nomlabofusp in pediatric patients with FA. We continue to enroll adolescents in our first cohort. This cohort will be followed ...

The following bupropion dosage chart highlights the basics, including the typical starting dose and the maximum or largest dose of bupropion per day. All doses are listed in milligrams (mg).